Fisher & Paykel Healthcare Launches F&P my820 System for Home-Based Respiratory Humidification in the USA

Published in Member Communities on August 09, 2024

F&P my820Fisher & Paykel Healthcare Corporation Limited has announced the launch of the F&P my820 System into the United States.

The F&P my820 is the company’s latest respiratory humidifier for home mechanical ventilation. The F&P my820 System provides heated humidification during the delivery of invasive ventilation, noninvasive ventilation, and humidified high-flow therapies for adult and pediatric patients.

“The F&P my820 is the result of years of dedicated investment in new technologies that improve care and outcomes for patients in their homes,” said Andrew Somervell, Vice President – Products & Technology. “It provides peace of mind that adults and children can continue to receive high-quality care after they leave the hospital.”

Designed specifically to perform in home environments where temperatures can fluctuate, the F&P my820 System automatically adapts to environmental temperature changes using a built-in sensor. This sensor works to mitigate circuit condensate while also reducing device-wire clutter and providing patients with a simplified set-up process.

The F&P my820 System is currently available in Australasia, Europe, Canada, and the United States, with more markets being added as regulatory clearances are received. DME customers in the United States can purchase the product starting August 1, 2024 by contacting their local Fisher & Paykel Healthcare sales representative. Product information can be found at fphcare.com.


TAGS

  1. respiratory
  2. vendor

From Our Experts

Embrace Your Inner Expert in Ventilation Management thumbnail Embrace Your Inner Expert in Ventilation Management Boone Lockard explains how the new ventilation NCD is elevating providers' roles as clinical partners focused on compliance and patient outcomes. Embrace Your Inner Expert in Ventilation Management thumbnail Embrace Your Inner Expert in Ventilation Management Boone Lockard explains how the new ventilation NCD is elevating providers' roles as clinical partners focused on compliance and patient outcomes. From Opportunity to Action: A More Proactive Approach to RePAP thumbnail From Opportunity to Action: A More Proactive Approach to RePAP Proactive RePAP strategies can help HMEs identify eligible patients, improve outreach, and support replacement opportunities before patients ask. From Opportunity to Action: A More Proactive Approach to RePAP thumbnail From Opportunity to Action: A More Proactive Approach to RePAP Proactive RePAP strategies can help HMEs identify eligible patients, improve outreach, and support replacement opportunities before patients ask. Are Your Ventilator Assets Supporting Growth or Holding It Back? thumbnail Are Your Ventilator Assets Supporting Growth or Holding It Back? Discover how a flexible ventilator asset strategy can reduce risk, improve cash flow, and support growth for respiratory providers. Are Your Ventilator Assets Supporting Growth or Holding It Back? thumbnail Are Your Ventilator Assets Supporting Growth or Holding It Back? Discover how a flexible ventilator asset strategy can reduce risk, improve cash flow, and support growth for respiratory providers. The Leadership Investment That Keeps Paying Dividends thumbnail The Leadership Investment That Keeps Paying Dividends Learn how connecting people to purpose and teaching the “why” builds stronger teams from VGM expert Stephanie Robinson, Director of Billing and Reimbursement. Prior Authorization Reminders for Complex Rehab Providers thumbnail Prior Authorization Reminders for Complex Rehab Providers VGM expert Dan Fedor explains prior authorization exemptions, common documentation and coding errors, K5 wheelchair requirements, and claim-level denials.